[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Quest Diagnostics Inc (DGX)

Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 26,794,150
  • Shares Outstanding, K 110,373
  • Annual Sales, $ 11,035 M
  • Annual Income, $ 992,000 K
  • EBIT $ 1,781 M
  • EBITDA $ 2,351 M
  • 60-Month Beta 0.56
  • Price/Sales 2.45
  • Price/Cash Flow 16.12
  • Price/Book 3.45

Options Overview Details

View History
  • Implied Volatility 20.69% (+0.83%)
  • Historical Volatility 26.57%
  • IV Percentile 18%
  • IV Rank 18.69%
  • IV High 39.24% on 07/22/26
  • IV Low 16.43% on 08/26/26
  • Expected Move (DTE 19) 10.54 (4.34%)
  • Put/Call Vol Ratio 1.14
  • Today's Volume 413
  • Volume Avg (30-Day) 466
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 7,020
  • Open Int (30-Day) 12,041
  • Expected Range 232.22 to 253.30

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $2.85
  • Number of Estimates 8
  • High Estimate $2.90
  • Low Estimate $2.82
  • Prior Year $2.60
  • Growth Rate Est. (year over year) +9.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
229.01 +6.00%
on 07/30/26
247.19 -1.79%
on 08/27/26
+6.82 (+2.89%)
since 07/28/26
3-Month
191.01 +27.09%
on 06/02/26
247.19 -1.79%
on 08/27/26
+46.56 (+23.73%)
since 05/28/26
52-Week
171.18 +41.82%
on 01/05/26
247.19 -1.79%
on 08/27/26
+63.56 (+35.47%)
since 08/28/25

Most Recent Stories

More News
Quest Diagnostics Stock: Is Wall Street Bullish or Bearish?

While Quest Diagnostics has outpaced the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

XLV : 171.16 (-0.24%)
DGX : 242.76 (-0.76%)
$SPX : 7,711.76 (-0.25%)
Quest Diagnostics to Speak at the Baird 2026 Global Healthcare Conference

SECAUCUS, N.J. , Aug. 25, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will...

DGX : 242.76 (-0.76%)
Humanity Brings Biological Age Analysis to the U.S. Through questhealth.com

Individuals in the U.S. can now add Humanity Biological Age's lab-informed insights to select health profile tests purchased through Quest's consumer-initiated testing platform

DGX : 242.76 (-0.76%)
Quest Diagnostics to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference

SECAUCUS, N.J. , Aug. 24, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President & Chief...

DGX : 242.76 (-0.76%)
Quest Diagnostics to Offer FDA-Cleared Roche pTau217 Blood Test to Assess Alzheimer's Disease Pathology

Test to join the company's expansive portfolio of Quest AD-Detect® blood tests for assessing symptomatic patients

DGX : 242.76 (-0.76%)
Digi Power X Reports Second Quarter 2026 Financial Results and Provides Operational Update and 2027 Outlook

Highlights $1.1 Billion of Contracted AI Infrastructure Revenue, First AI Compute Revenue, Positive Adjusted EBITDA and Strong Balance Sheet

DGX : 242.76 (-0.76%)
DGX.NE : 5.2300 (-6.94%)
DGX.VN : 3.790 (+5.28%)
DGXX : 3.73 (-7.44%)
Quest Diagnostics Declares Quarterly Cash Dividend

SECAUCUS, N.J. , Aug. 12, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash...

DGX : 242.76 (-0.76%)
Digi Power X to Announce 2026 Q2 Financial Results and Provide Operations Update on August 14th

MIAMI, FL / ACCESS Newswire / August 4, 2026 / Digi Power X Inc. (NASDAQ:DGXX)(Cboe Canada:DGX) (the "Company" or "Digi Power X"), an AI data center infrastructure operator, plans to announce its financial...

DGX : 242.76 (-0.76%)
DGX.NE : 5.2300 (-6.94%)
DGX.VN : 3.790 (+5.28%)
DGXX : 3.73 (-7.44%)
Bacterial Vaginosis Linked to Increased STI Co-Infection, Finds National Study of 1.5 Million Women from Quest Diagnostics

Largest nationally representative study finds 12% of patients positive for bacterial vaginosis are infected with at least one STI, such as chlamydia or gonorrhea

DGX : 242.76 (-0.76%)
Quest’s (NYSE:DGX) Q2 CY2026: Beats On Revenue, Stock Soars

Quest’s (NYSE:DGX) Q2 CY2026: Beats On Revenue, Stock Soars

DGX : 242.76 (-0.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 70%. The market has dropped from overbought territory. Beware of a potential mean reversion.

See More Share

Business Summary

Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services...

See More

Key Turning Points

3rd Resistance Point 247.61
2nd Resistance Point 246.45
1st Resistance Point 244.60
Last Price 242.76
1st Support Level 241.59
2nd Support Level 240.43
3rd Support Level 238.58

See More

52-Week High 247.19
Last Price 242.76
Fibonacci 61.8% 218.15
Fibonacci 50% 209.18
Fibonacci 38.2% 200.21
52-Week Low 171.18

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.